Literature DB >> 12788989

Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats.

Sthephen L Leib1, Chris Heimgartner, Yoeng-Delphine Bifrare, Jutta M Loeffler, Martin G Täauber.   

Abstract

In an infant rat model of pneumococcal meningitis the effect of dexamethasone on neuronal injury in the hippocampus and on learning disability after recovery from the disease was examined. Treatment with dexamethasone or vehicle was started 18 h after infection, concomitant with antibiotics. Neuronal apoptosis in the hippocampal dentate gyrus 34 h after infection was significantly aggravated by dexamethasone treatment compared with vehicle controls (p = 0.02). Three weeks after acute pneumococcal meningitis, learning capacity of animals was assessed in the Morris water maze. The results showed a significantly impaired learning performance of infected animals treated with dexamethasone compared with vehicle controls (p = 0.01). Dexamethasone had no effect on hippocampal injury or learning in uninfected controls. Thus, dexamethasone as adjuvant therapy increased hippocampal cell injury and reduced learning capacity in this model of pneumococcal meningitis in infant rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788989     DOI: 10.1203/01.PDR.0000079185.67878.72

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  44 in total

1.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

2.  Adjunctive Corticosteroids in Adults with Bacterial Meningitis.

Authors:  Diederik van de Beek; Jan de Gans
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

Review 3.  Meta-analysis of adjunctive dexamethasone to improve clinical outcome of bacterial meningitis in children.

Authors:  Ying Wang; Xinjie Liu; Yuzhen Wang; Qi Liu; Cuicui Kong; Guixia Xu
Journal:  Childs Nerv Syst       Date:  2017-11-29       Impact factor: 1.475

Review 4.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.

Authors:  Denis Grandgirard; Christian Schürch; Philippe Cottagnoud; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

6.  Cronobacter sakazakii Infection in Early Postnatal Rats Impaired Contextual-Associated Learning: a Putative Role of C5a-Mediated NF-κβ and ASK1 Pathways.

Authors:  Ponnusamy Vinay; Christopher Karen; Krishnaswamy Balamurugan; Koilmani Emmanuvel Rajan
Journal:  J Mol Neurosci       Date:  2020-06-21       Impact factor: 3.444

Review 7.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  IL-10 administration reduces PGE-2 levels and promotes CR3-mediated clearance of Escherichia coli K1 by phagocytes in meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Ashok Panigrahy; Kerstin Goth; Richard Bonnet; Nemani V Prasadarao
Journal:  J Exp Med       Date:  2010-05-24       Impact factor: 14.307

9.  Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis.

Authors:  Matthias Wittwer; Denis Grandgirard; Janine Rohrbach; Stephen L Leib
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

10.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.